144 related articles for article (PubMed ID: 2199982)
21. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Chen CJ; Zhang YJ; Lu SN; Santella RM
Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
[TBL] [Abstract][Full Text] [Related]
22. Immunological methods for detection of carcinogen-DNA damage in humans.
Santella RM
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):733-9. PubMed ID: 10498391
[TBL] [Abstract][Full Text] [Related]
23. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
[TBL] [Abstract][Full Text] [Related]
24. Detection of benzo[a]pyrene-DNA adducts in cultured cells treated with benzo[a]pyrene diol-epoxide by quantitative immunofluorescence microscopy and 32P-postlabelling; immunofluorescence analysis of benzo[a]pyrene-DNA adducts in bronchial cells from smoking individuals.
Baan RA; van den Berg PT; Steenwinkel MJ; van der Wulp CJ
IARC Sci Publ; 1988; (89):146-54. PubMed ID: 3143666
[TBL] [Abstract][Full Text] [Related]
25. Development of a monoclonal antibody recognizing benzo[c]phenanthrenediol epoxide-DNA adducts: application to immunohistochemical detection of DNA damage.
Zhang YJ; Geacintov NE; Santella RM
Chem Res Toxicol; 1997 Sep; 10(9):948-52. PubMed ID: 9305575
[TBL] [Abstract][Full Text] [Related]
26. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
Shields PG; Bowman ED; Harrington AM; Doan VT; Weston A
Cancer Res; 1993 Aug; 53(15):3486-92. PubMed ID: 8339251
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
28. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
29. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
[TBL] [Abstract][Full Text] [Related]
30. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers.
Zhang YJ; Hsu TM; Santella RM
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):133-8. PubMed ID: 7537994
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes.
Motykiewicz G; Małusecka E; Grzybowska E; Chorazy M; Zhang YJ; Perera FP; Santella RM
Cancer Res; 1995 Apr; 55(7):1417-22. PubMed ID: 7533662
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric analysis of 8-methoxypsoralen-DNA photoadducts in human keratinocytes.
Yang XY; Delohery T; Santella RM
Cancer Res; 1988 Dec; 48(24 Pt 1):7013-7. PubMed ID: 2461251
[TBL] [Abstract][Full Text] [Related]
33. Monitoring human exposure to carcinogens by DNA adduct measurement.
Santella RM
Cell Biol Toxicol; 1988 Dec; 4(4):511-6. PubMed ID: 3228719
[TBL] [Abstract][Full Text] [Related]
34. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
[TBL] [Abstract][Full Text] [Related]
35. A comparison of 32P-postlabelling and immunological methods to examine human lung DNA for benzo[a]pyrene adducts.
Garner RC; Tierney B; Phillips DH
IARC Sci Publ; 1988; (89):196-200. PubMed ID: 3143669
[TBL] [Abstract][Full Text] [Related]
36. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
37. Immunologic quantification of carcinogen-DNA adducts.
Santella RM; Hsieh LL; Perera F
Basic Life Sci; 1986; 38():509-17. PubMed ID: 3090996
[TBL] [Abstract][Full Text] [Related]
38. Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype.
Santella RM; Perera FP; Young TL; Zhang YJ; Chiamprasert S; Tang D; Wang LW; Beachman A; Lin JH; DeLeo VA
Mutat Res; 1995 Apr; 334(2):117-24. PubMed ID: 7885362
[TBL] [Abstract][Full Text] [Related]
39. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood.
Hsieh LL; Hsieh TT
Cancer Res; 1993 Mar; 53(6):1278-80. PubMed ID: 8383006
[TBL] [Abstract][Full Text] [Related]
40. Detection and characterization of human serum antibodies to polycyclic aromatic hydrocarbon diol-epoxide DNA adducts.
Newman MJ; Light BA; Weston A; Tollurud D; Clark JL; Mann DL; Blackmon JP; Harris CC
J Clin Invest; 1988 Jul; 82(1):145-53. PubMed ID: 3392204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
